Skip to content

Frequency of Diagnostic Symptomatic Pulmonary Embolism's in Patients Hospitalized for Clinical Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Frequency of Diagnostic Symptomatic Pulmonary Embolism's in Patients Hospitalized for Clinical Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02035293
Acronym
PEP
Enrollment
750
Registered
2014-01-14
Start date
2014-01-08
Completion date
2017-10-13
Last updated
2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, Patients Hospitalized for a COPD Exacerbation

Keywords

COPD Exacerbation, Pulmonary embolism, Standardized and consensus diagnostic strategy

Brief summary

A standardized diagnostic strategy of pulmonary embolism will be applied to eligible patients, incorporating a clinical probability score (revised Geneva score), plasma D-dimer assay and if necessary, a multidetector-row CT angiography thoracic and venous ultrasound of the lower limbs. All the patient with a pulmonary embolism diagnosed or not, will be followed for 3 months.

Interventions

OTHERPEP

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients hospitalized for a COPD exacerbation * COPD previously diagnosed

Exclusion criteria

* Allergy to iodinated contrast * Creatinine clearance \< 30 mL / min * Patient hospitalized for exacerbation of COPD for more than 48 hours * Pneumothorax * Exams impossible to be performed * Pregnancy * Life expectancy \< 3 months * Patients already receiving anticoagulant therapy for another reason (mechanical valve, cardiac arrhythmia).

Design outcomes

Primary

MeasureTime frame
Frequency of pulmonary embolism in patients hospitalized for a clinical exacerbation of COPD.27 months

Secondary

MeasureTime frame
The rate of pulmonary embolism diagnosed during the 3 month follow-up in patients whom pulmonary embolism was initially excluded when they've been included in the study27 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026